Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,400 | 90,733 | 102,220 | 113,032 | 123,177 |
| Receivables | 50,810 | 50,427 | 47,369 | 53,908 | 52,793 |
| Inventories | 90,238 | 124,185 | 120,055 | 81,835 | 100,839 |
| TOTAL | $224,448 | $265,345 | $269,644 | $248,775 | $276,809 |
| Non-Current Assets | |||||
| PPE Net | 6,738 | 7,109 | 7,110 | 7,416 | 8,402 |
| Intangibles | 503,940 | 490,520 | 508,263 | 557,454 | 568,607 |
| Other Non-Current Assets | 1,749 | 1,770 | 1,850 | 1,885 | 1,646 |
| TOTAL | $512,427 | $499,399 | $517,223 | $566,755 | $578,655 |
| Total Assets | $736,875 | $764,744 | $786,867 | $815,530 | $855,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 134,947 | 127,909 | 136,752 | 149,734 | 124,315 |
| Other current liabilities | 8,197 | 17,401 | 6,957 | 7,545 | 29,527 |
| TOTAL | $143,144 | $151,028 | $143,709 | $157,279 | $153,842 |
| Non-Current Liabilities | |||||
| Long Term Debt | 98,945 | 98,726 | 98,463 | 93,395 | 91,820 |
| Other Non-Current Liabilities | 164,700 | 166,708 | 192,048 | 190,950 | 266,778 |
| TOTAL | $269,454 | $271,682 | $297,176 | $299,489 | $395,599 |
| Total Liabilities | $412,598 | $422,710 | $440,885 | $456,768 | $549,441 |
| Shareholders' Equity | |||||
| Common Shares | 25,561 | 25,586 | 25,572 | 25,500 | 25,261 |
| Retained earnings | -271,388 | -248,693 | -246,676 | -231,194 | -276,096 |
| Other shareholders' equity | 247,122 | 242,001 | 247,231 | 246,303 | 246,080 |
| TOTAL | $324,277 | $342,034 | $345,982 | $358,762 | $306,023 |
| Total Liabilities And Equity | $736,875 | $764,744 | $786,867 | $815,530 | $855,464 |